Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ligand- and Heterodimer-Directed Signaling of the CB1 Cannabinoid Receptor
Brian D. Hudson, Terence E. Hébert, Michael E. Kelly
Molecular Pharmacology (2009) Vol. 77, Iss. 1, pp. 1-9
Closed Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Shenglong Zou, Ujendra Kumar
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 3, pp. 833-833
Open Access | Times Cited: 1108
Endocannabinoid Signaling and Synaptic Function
Pablo E. Castillo, Thomas J. Younts, Andrés E. Chávez, et al.
Neuron (2012) Vol. 76, Iss. 1, pp. 70-81
Open Access | Times Cited: 1008
Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids
Kathryn A. Seely, Jeff Lapoint, Jeffery H. Moran, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2012) Vol. 39, Iss. 2, pp. 234-243
Open Access | Times Cited: 455
From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
Alessia Ligresti, Luciano De Petrocellis, Vincenzo Di Marzo
Physiological Reviews (2016) Vol. 96, Iss. 4, pp. 1593-1659
Open Access | Times Cited: 414
Towards the use of cannabinoids as antitumour agents
Guillermo Velasco, Cristina Sánchez, Manuel Guzmán
Nature reviews. Cancer (2012) Vol. 12, Iss. 6, pp. 436-444
Closed Access | Times Cited: 349
CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity
Arnau Busquets‐Garcia, Jaideep S. Bains, Giovanni Marsicano
Neuropsychopharmacology (2017) Vol. 43, Iss. 1, pp. 4-20
Open Access | Times Cited: 278
Bimodal control of stimulated food intake by the endocannabinoid system
Luigi Bellocchio, Pauline Lafenêtre, Astrid Cannich, et al.
Nature Neuroscience (2010) Vol. 13, Iss. 3, pp. 281-283
Open Access | Times Cited: 273
Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies
Mauro Maccarrone, Manuel Guzmán, Ken Mackie, et al.
Nature reviews. Neuroscience (2014) Vol. 15, Iss. 12, pp. 786-801
Open Access | Times Cited: 271
The cannabinoid system and pain
Stephen G. Woodhams, Victoria Chapman, David P. Finn, et al.
Neuropharmacology (2017) Vol. 124, pp. 105-120
Open Access | Times Cited: 239
Allostery at G Protein-Coupled Receptor Homo- and Heteromers: Uncharted Pharmacological Landscapes
Nicola J. Smith, Graeme Milligan
Pharmacological Reviews (2010) Vol. 62, Iss. 4, pp. 701-725
Open Access | Times Cited: 246
Pharmacological characterization of GPR55, a putative cannabinoid receptor
Haleli Sharir, Mary E. Abood
Pharmacology & Therapeutics (2010) Vol. 126, Iss. 3, pp. 301-313
Open Access | Times Cited: 217
Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunities
Barbara Bosier, Giulio G. Muccioli, Emmanuel Hermans, et al.
Biochemical Pharmacology (2010) Vol. 80, Iss. 1, pp. 1-12
Closed Access | Times Cited: 181
Ischemic stroke after use of the synthetic marijuana “spice”
Melissa Freeman, David Z. Rose, Martin Myers, et al.
Neurology (2013) Vol. 81, Iss. 24, pp. 2090-2093
Open Access | Times Cited: 132
Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists
Elise Wouters, Jolien Walraed, Samuel D. Banister, et al.
Biochemical Pharmacology (2019) Vol. 169, pp. 113623-113623
Closed Access | Times Cited: 79
Cannabinoid receptor 1 ligands: Biased signaling mechanisms driving functionally selective drug discovery
Lei Tian, Taotao Qiang, Shanglong Liu, et al.
Pharmacology & Therapeutics (2025), pp. 108795-108795
Closed Access | Times Cited: 1
Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety—two sides of one coin?
Fabrício A. Moreira, Daniele C. Aguiar, Ana Luisa B. Terzian, et al.
Neuroscience (2011) Vol. 204, pp. 186-192
Closed Access | Times Cited: 109
Heteromultimerization of Cannabinoid CB1 Receptor and Orexin OX1 Receptor Generates a Unique Complex in Which Both Protomers Are Regulated by Orexin A
Richard J. Ward, John D. Pediani, Graeme Milligan
Journal of Biological Chemistry (2011) Vol. 286, Iss. 43, pp. 37414-37428
Open Access | Times Cited: 91
The CXC Chemokine Receptor 4 Ligands Ubiquitin and Stromal Cell-derived Factor-1α Function through Distinct Receptor Interactions
Vikas Saini, Daniel M. Staren, Joshua J. Ziarek, et al.
Journal of Biological Chemistry (2011) Vol. 286, Iss. 38, pp. 33466-33477
Open Access | Times Cited: 88
Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets
Srikrishnan Mallipeddi, David R. Janero, Nikolai Zvonok, et al.
Biochemical Pharmacology (2016) Vol. 128, pp. 1-11
Open Access | Times Cited: 81
The Cannabinoid Receptor CB1 Interacts with the WAVE1 Complex and Plays a Role in Actin Dynamics and Structural Plasticity in Neurons
Christian Njoo, Nitin Agarwal, Beat Lutz, et al.
PLoS Biology (2015) Vol. 13, Iss. 10, pp. e1002286-e1002286
Open Access | Times Cited: 79
Multiple Mechanistically Distinct Modes of Endocannabinoid Mobilization at Central Amygdala Glutamatergic Synapses
Teniel S Ramikie, Rita Nyilas, Rebecca J. Bluett, et al.
Neuron (2014) Vol. 81, Iss. 5, pp. 1111-1125
Open Access | Times Cited: 77
Cannabinoid receptor ligand bias: implications in the central nervous system
Robert B. Laprairie, Amina M. Bagher, Eileen M. Denovan‐Wright
Current Opinion in Pharmacology (2016) Vol. 32, pp. 32-43
Closed Access | Times Cited: 63
5-Chlorobenzofuran-2-carboxamides: From allosteric CB1 modulators to potential apoptotic antitumor agents
Bahaa G. M. Youssif, Ashraf M. Mohamed, Essam Eldin A. Osman, et al.
European Journal of Medicinal Chemistry (2019) Vol. 177, pp. 1-11
Closed Access | Times Cited: 55
N-Arachidonyl Glycine Does Not Activate G Protein–Coupled Receptor 18 Signaling via Canonical Pathways
Van B. Lu, Henry L. Puhl, Stephen R. Ikeda
Molecular Pharmacology (2012) Vol. 83, Iss. 1, pp. 267-282
Open Access | Times Cited: 62
Atypical Endocannabinoid Signaling Initiates a New Form of Memory-Related Plasticity at a Cortical Input to Hippocampus
Weisheng Wang, Yousheng Jia, Danielle T. Pham, et al.
Cerebral Cortex (2017) Vol. 28, Iss. 7, pp. 2253-2266
Open Access | Times Cited: 61
Page 1 - Next Page

Scroll to top